Skip to main content
IRMD logo

IRADIMED CORPORATION

IRMDNASDAQHealthcareMedical Devices

$85.35Today:+$0.12 (+0.14%)1Y +1.19%

As of Nov 13, 2026 close

Market cap
$1.10B
P/E (TTM)
45.82
Forward P/E
40.46
Dividend yield
1.72%
52-week range
$76.35$107.90
Volume (live)
-
Avg. volume (3M)
120.37K

IRADIMED (IRMD) Stock Price & Financial Analysis

IRADIMED Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$84.29 - $86.17
52-Week High$107.90
52-Week Low$76.35
Open$85.19
Volume (last close)115.21K
Average Volume (3M)120.37K
Earnings & Profitability
Revenue (TTM)89.34M
Net Income (TTM)23.98M
Free Cash Flow (TTM)25.69M
EPS (TTM)$1.86
Profit Margin26.85%
Operating Margin32.30%
Return on Equity (ROE)22.53%
Debt to Equity0.00
Dividend Information
Annual Dividend$1.47
Dividend Yield1.72%
Payout Ratio78.90%
Last Dividend Ex-DateNov 13, 2026
Size & Valuation
Market Cap1.10B
Shares Outstanding12.88M
P/E Ratio (TTM)45.82
Forward P/E40.46
Price to Sales (P/S)12.30
Price to Book (P/B)10.32
EV/EBITDA32.93
Technical Indicators
50-Day MA$85.30
200-Day MA$91.74
1-Year Change+1.19%

Source: Market prices and company fundamentals. Data as of Nov 13, 2026. Data sources and methodology

Compare IRMD with other stocks

IRADIMED at a Glance

As of the Nov 13, 2026 close, IRADIMED (IRMD) has a market capitalization of $1.10B. The stock trades at 45.8× trailing earnings, 40.5× forward earnings and 12.3× sales. Over the trailing twelve months it earned $23.98M on revenue of $89.34M (a 26.9% profit margin) and generated $25.69M of free cash flow. Revenue grew 11.0% year over year.

As of its latest reported balance sheet, it holds $63.29M in cash and securities against $0.00 of debt, a net cash position of $63.29M.

IRADIMED pays a quarterly dividend totaling $1.47 per share a year, a 1.72% yield at the Nov 13, 2026 close, with a 79% payout ratio and 1 consecutive year of dividend increases.

The share price is up 1.2% over the past year. At $85.35 (the Nov 13, 2026 close) it sits within its 52-week range of $76.35 to $107.90, below its 200-day moving average of $91.74.

ETFs Holding IRMD

Largest funds holding IRMD, by assets

As of Oct 4, 2026, IRADIMED (IRMD) is among the top 50 holdings of 2 US ETFs.

Largest ETFs holding IRMD by assets
ETFNameWeightAUMExpense Ratio
IHIiShares U.S. Medical Devices ETF0.10%$3.53B0.37%
AIMSAcuitas Small Cap Active ETF1.11%$84.18M0.75%

Source: ETF top holdings as reported by fund issuers (largest ~50 positions per fund). Data as of Oct 4, 2026. Data sources and methodology

Find more ETFs in the ETF screener

Frequently Asked Questions About IRADIMED

What is the current stock price for IRMD?

As of the Nov 13, 2026 close, IRMD stock trades at $85.35. The 52-week range is $76.35–$107.90, with a day range of $84.29–$86.17.

What is the P/E ratio for IRMD?

As of the Nov 13, 2026 close, IRADIMED's trailing twelve-month (TTM) P/E ratio is 45.8, meaning investors pay $45.8 for every $1 of annual earnings. The forward P/E is 40.5, reflecting analyst expectations for future earnings. IRADIMED operates in the Healthcare sector.

Does IRMD pay dividends?

Yes, IRADIMED pays a 1.72% annual dividend yield as of the Nov 13, 2026 close ($1.47 per share a year). The trailing twelve-month payout ratio is 78.9%. The most recent ex-dividend date was November 13, 2026.

What is the market cap of IRMD?

As of the Nov 13, 2026 close, IRADIMED's market capitalization is $1.10B, classifying it as a small-cap company. IRADIMED operates in the Healthcare sector within the Medical Devices industry.